Australian biotech bodies propose tax incentive to the senate as a boost to domestic innovation

15 August 2014
2019_biotech_test_vial_discovery_big

Australian biotech industry leaders including AusBiotech, Cook Medical Australia and the Export Council of Australia have proposed an Australian Innovation & Manufacturing Incentive in their submission to the senate’s inquiry into the state of innovation in the country.

The proposed incentive would encourage companies to commercialize intellectual property in and from Australia, and works by providing a reduction in the tax payable on profits that come from the commercialization of certain intellectual property (mainly patents or licenses to patents) in Australia.

The group made the proposal collectively and is asking the government to channel it into the National Industry Investment and Competitiveness Agenda.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Biotechnology